Package 72888-182-30

Brand: buprenorphine hydrochloride

Generic: buprenorphine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72888-182-30
Digits Only 7288818230
Product NDC 72888-182
Description

30 TABLET in 1 BOTTLE (72888-182-30)

Marketing

Marketing Status
Marketed Since 2024-01-23
Brand buprenorphine hydrochloride
Generic buprenorphine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "47a1af00-e74e-d1cc-e063-6394a90ab889", "openfda": {"upc": ["0372888183909", "0372888182308", "0372888183305", "0372888182902"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["699638dd-3a53-445f-a545-d0e6eabfe1c9"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72888-182-30)", "package_ndc": "72888-182-30", "marketing_start_date": "20240123"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72888-182-90)", "package_ndc": "72888-182-90", "marketing_start_date": "20240123"}], "brand_name": "buprenorphine hydrochloride", "product_id": "72888-182_47a1af00-e74e-d1cc-e063-6394a90ab889", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "72888-182", "dea_schedule": "CIII", "generic_name": "buprenorphine hydrochloride", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "buprenorphine hydrochloride", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA090279", "marketing_category": "ANDA", "marketing_start_date": "20150610", "listing_expiration_date": "20271231"}